Sec. 207. Support for efforts of the Global Fund to Fight Aids, Tuberculosis and Malaria to respond to COVID–19
191 words·~1 min read·
/bill/116/s/3669/is/section-207A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
It is the sense of Congress that— the COVID–19 pandemic threatens gains made through decades of investments to combat the spread of AIDS, tuberculosis, and malaria; COVID–19 poses a threat to the health systems of resource-constrained countries, including strains on laboratory capacity and supply chains for health commodities, as well as availability of healthcare workers and equipment and supplies; interruptions in treatment for AIDS, tuberculosis, and malaria due to disruptions in supply chains for critical drugs and medical equipment and supplies, as well as the diversion of healthcare workers, could significantly increase the death toll from AIDS, tuberculosis, and malaria, potentially exceeding the number of deaths from COVID–19 itself; and the Global Fund to Fight AIDS, Tuberculosis and Malaria has a strong track record of working with partners in resource-constrained settings to ensure delivery of services and commodities.
Notwithstanding section 202(d)(4)(A)(i) of the United States Leadership Against HIV/AIDS, Tuberculosis, and Malaria Act of 2003 ( 22 U.S.C. 7622(d)(4)(A)(i) ), there is authorized to be appropriated $1,000,000,000 for an immediate contribution to the Global Fund to Fight AIDS, Tuberculosis and Malaria, specifically for its COVID–19 response mechanism, to be available until expended.
Connectionstraces to 1
Traces to 1 document
Citation graph
cites case law
Sec. 207
Support for efforts of the Global Fund to Fight Aids, Tuberculosis and Malaria to respond to COVID–19
Cites 1Cited by 0 across 0 sources